Clinical Genitourinary Cancer

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Aim and Scope

Clinical Genitourinary Cancer is a peer-reviewed quarterly journal that publishes original articles describing various aspects of clinical and translational research of prostate, urinary, and renal cancers.
Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of prostate, urinary, and renal cancers. The main emphasis is on recent scientific developments in all areas related to these cancers.
Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

About Clinical Genitourinary Cancer

Clinical Genitourinary Cancer is a journal covering the technologies/fields/categories related to Urology (Q1); Oncology (Q2). It is published by Elsevier. The overall rank of Clinical Genitourinary Cancer is 4020. According to SCImago Journal Rank (SJR), this journal is ranked 1.031. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 54. The best quartile for this journal is Q1.

The ISSN of Clinical Genitourinary Cancer journal is 15587673. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Genitourinary Cancer is cited by a total of 1491 articles during the last 3 years (Preceding 2022).

Clinical Genitourinary Cancer Impact IF 2022-2023

The Impact IF 2022 of Clinical Genitourinary Cancer is 3.09, which is computed in 2023 as per its definition. Clinical Genitourinary Cancer IF is increased by a factor of 0.15 and approximate percentage change is 5.1% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Clinical Genitourinary Cancer Impact IF 2023 Prediction

Impact IF 2022 of Clinical Genitourinary Cancer is 3.09. If the same upward trend persists, Impact IF may rise in 2023 as well.

Clinical Genitourinary Cancer h-index

 

Clinical Genitourinary Cancer has an h-index of 54. It means 54 articles of this journal have more than 54 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.

Clinical Genitourinary Cancer ISSN

The ISSN of Clinical Genitourinary Cancer is 15587673. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Clinical Genitourinary Cancer Rank and SCImago Journal Rank (SJR)

The overall rank of Clinical Genitourinary Cancer is 4020. According to SCImago Journal Rank (SJR), this journal is ranked 1.031. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Clinical Genitourinary Cancer by Year

Ranking of Clinical Genitourinary Cancer by Year

Clinical Genitourinary Cancer Publisher

Clinical Genitourinary Cancer is published by Elsevier. It's publishing house is located in United States. Coverage history of this journal is as following: 2005-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.

Call For Papers

Visit the official website of the journal/conference to check the further details about the call for papers.

Abbreviation

The IS0 4 standard abbreviation of Clinical Genitourinary Cancer is Clin. Genitourin. Cancer. This abbreviation ('Clin. Genitourin. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.

How to publish in Clinical Genitourinary Cancer

If your research field is/are related to Urology (Q1); Oncology (Q2), then please visit the official website of this journal.

Acceptance Rate

The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

• The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
• Peer review complexity and timeline.
• The mix of unsolicited and invited submissions.
• The time it takes from manuscript submission to final publication.
• And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/